MAPK3 and cardiac hypertrophy: Thus, these findings together demonstrated the pathophysiological importance of PGE2 signaling through EP4-EGFR-ERK1/2-Stat3 cascade that was involved in the development of cardiac hypertrophy (Figure 3).